Try our corporate solution for free!
(212) 419-8286

Covid-19 impact: global pharma specialty excipient demand CAGR 2019-2024

It is estimated that from 2019 to 2024 the CAGR of the demand for pharmaceutical specialy excipients will be approximately 6.5 percent in a best case scenario. The growth between 2019 and 2020 will probably be around -1.5 percent due to the impact of the coronavirus.

Forecasted CAGR for pharmaceutical specialty excipient demand due to COVID-19 worldwide in 2019-2024*

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

May 2020



Survey time period

as of May 2020

Supplementary notes

* For oral solid dosage forms (OSDF).

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Coronavirus: the pharma and medtech response"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.